Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

AI and new therapies show promise in medicine, especially for cancer and regenerative treatments.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

TB lymphadenitis can occur in people with weakened immune systems, like those with SLE.

Methotrexate can help some kids with severe hair loss regrow hair.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

CS12192 effectively treats alopecia areata with better safety than current options.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

The excimer laser may help hair regrow in alopecia areata patients.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Leflunomide and anthralin may effectively treat severe alopecia areata.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.